Picture 1 of 12
Picture 1 of 12
ORPHAN DRUGS: UNDERSTANDING THE RARE DISEASE MARKET AND By Elizabeth
US $120.00
Approximately£94.00
or Best Offer
Condition:
Postage:
Located in: Hedgesville, West Virginia, United States
Delivery:
Estimated between Fri, 21 Jun and Wed, 26 Jun to 43230
Returns:
Payments:
Shop with confidence
Seller assumes all responsibility for this listing.
eBay item number:335046536707
Item specifics
- Condition
- Book Title
- Orphan Drugs: Understanding the Rare Disease Market and its
- ISBN-10
- 1907568093
- Subject
- Industries / Pharmaceutical & Biotechnology, Infectious Diseases, Pharmacology
- ISBN
- 9781907568091
- Subject Area
- Business & Economics, Medical
- Publication Name
- Orphan Drugs : Understanding the Rare Disease Market and Its Dynamics
- Item Length
- 9.2 in
- Publisher
- Elsevier Science & Technology
- Publication Year
- 2013
- Series
- Woodhead Publishing Series in Biomedicine Ser.
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Item Height
- 0.8 in
- Item Width
- 6.1 in
- Item Weight
- 22.9 Oz
- Number of Pages
- 334 Pages
About this product
Product Information
This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient groups.The journey from application of an orphan drug designation to a reimbursed market- approved drug is long and many obstacles occur during the journey.After reading the book, readers will: Understand who the players/stakeholders are in the rare orphan disease field and their specific needs and concerns: patients and patient organizations, researchers and treating physicians within the field, industry, regulatory and reimbursement bodies* Understand the strong partnership between the different players and the various initiatives to improve and increase access to treatment for patients; minimizing the gap between numbers of known diseases, orphan designations, approved drugs and paid drugs.The book also provides short practical case stories from patients and researchers, as well as representatives from industry and authorities on the challenges they came across in developing orphan drugs or getting access to orphan drugs.
Product Identifiers
Publisher
Elsevier Science & Technology
ISBN-10
1907568093
ISBN-13
9781907568091
eBay Product ID (ePID)
109309079
Product Key Features
Publication Name
Orphan Drugs : Understanding the Rare Disease Market and Its Dynamics
Format
Hardcover
Language
English
Subject
Industries / Pharmaceutical & Biotechnology, Infectious Diseases, Pharmacology
Publication Year
2013
Series
Woodhead Publishing Series in Biomedicine Ser.
Type
Textbook
Subject Area
Business & Economics, Medical
Number of Pages
334 Pages
Dimensions
Item Length
9.2 in
Item Height
0.8 in
Item Width
6.1 in
Item Weight
22.9 Oz
Additional Product Features
Lc Classification Number
Hd9675
Table of Content
List of figures and tables Acknowledgements About the authors Chapter 1: Introduction Chapter 2: Orphan drugs and orphan drug legislation Abstract: 1.1 The history of orphan drug legislation 1.2 Legislation and the definition of orphan disease in different countries 1.3 Current state of the art: number of designations and approvals 1.4 Players on the market 1.5 Contribution made by orphan drug legislation 1.6 Procedure: orphan drug designation and marketing authorisation approval 1.7 External links and sources of further information Chapter 3: Characteristics of rare diseases Abstract: 2.1 Definition of rare diseases, prevalence, incidence and coverage by the International Classification of Diseases (ICD) 2.2 Characteristics of rare diseases, genetics and underlying causes 2.3 Common problems encountered with rare diseases 2.4 Patient care, management and counselling 2.5 Examples of rare diseases 2.6 Public awareness and disease support groups 2.7 Resources and external links Chapter 4: Patient network and advocacy groups Abstract: 3.1 Patient empowerment through international institutions: WHO and EU 3.2 The role of patient organisations and advocacy groups: the needs, strategies, objectives and achievements 3.3 Patients and research: patients' engagement and empowerment within rare diseases 3.4 Umbrella organisations: EURORDIS and NORD 3.5 National European organisations 3.6 Other organisations working in the Americas 3.7 Organisations working in Africa, Asia and Australasia 3.8 Other patient alliances 3.9 Organisations dedicated to a specific disease 3.10 Virtual health communities Chapter 5: Organisations and networks dedicated to rare diseases and orphan drugs Abstract: 4.1 Organisations and networks: their roles and activities 4.2 European organisations and networks 4.3 American organisations and networks 4.4 International organisations and networks Chapter 6: Policies and research funding Abstract: 5.1 Policies on rare diseases 5.2 Research funding in the European Union (EU) 5.3 Research funding in the USA 5.4 Collaborative activities and joint funding 5.5 External links and sources of further information Chapter 7: Designing robust clinical trials for orphan drugs Abstract: 6.1 Review of hurdles and implications for study design 6.2 Finding relevant study endpoints 6.3 Sample size and demonstration of superiority for market approval and HTA evaluation 6.4 The need for long-term collaborative effort in collecting real-world safety and effectiveness data 6.5 Notes Chapter 8: Market access procedures for orphan drugs Abstract: 7.1 What is meant by market - or patient - access? 7.2 Market approval versus market access 7.3 Differences in access procedures for orphan drugs by country 7.4 Availability and access to orphan drugs 7.5 Difficulties in estimating the value of treatment 7.6 Differences in patient access schemes and patient registries 7.7 Patient involvement in HTA 7.8 Compassionate use (expanded access) Index
Copyright Date
2013
Target Audience
Scholarly & Professional
Dewey Decimal
337.476151
Dewey Edition
23
Item description from the seller
Seller assumes all responsibility for this listing.
eBay item number:335046536707
Post to me
Item location:
Hedgesville, West Virginia, United States
Posts to:
Afghanistan, Albania, Algeria, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan Republic, Bahamas, Bahrain, Bangladesh, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde Islands, Cayman Islands, Central African Republic, Chad, Chile, China, Colombia, Costa Rica, Cyprus, Czech Republic, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Denmark, Djibouti, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Fiji, Finland, France, Gabon Republic, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Mauritania, Mauritius, Mexico, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, Norway, Oman, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Republic of Croatia, Republic of the Congo, Romania, Rwanda, Saint Kitts-Nevis, Saint Lucia, Saint Vincent and the Grenadines, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, South Korea, Spain, Sri Lanka, Suriname, Swaziland, Sweden, Switzerland, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Uganda, United Arab Emirates, United Kingdom, United States, Uruguay, Uzbekistan, Vanuatu, Vatican City State, Vietnam, Wallis and Futuna, Western Samoa, Yemen, Zambia, Zimbabwe
Excludes:
Barbados, French Guiana, French Polynesia, Guadeloupe, Libya, Martinique, New Caledonia, Reunion, Russian Federation, Ukraine, Venezuela
| Postage and packaging | To | Service | Delivery*See Delivery notes |
|---|---|---|---|
| US $4.87 (approx £3.81) | United States | Economy Delivery (USPS Media MailTM) | Estimated between Fri, 21 Jun and Wed, 26 Jun to 43230 |
| Dispatch time |
|---|
| Will usually dispatch within 3 working days of receiving cleared payment. |
| Taxes |
|---|
| Taxes may be applicable at checkout. Learn moreLearn more about paying tax on eBay purchases. |
Returns policy
| Return policy details |
|---|
| The seller won't accept returns for this item. |
Sellers may be required to accept returns for items that are not as described. Learn more about your rights as a buyer.
Refer to eBay return policyopens in a new tab or window for more details. You're covered by the eBay Money Back Guaranteeopens in a new tab or window if you receive an item that is not as described in the listing.
Payment details
Payment methods
Registered as a private seller
Thereby, consumer rights stemming from EU consumer protection law do not apply. eBay buyer protection still applies to most purchases.
Seller Feedback (1,038)
f***9 (208)- Feedback left by buyer.
Past 6 months
Verified purchase
100% Satisfied! Smooth transaction, Great item exactly as described, Fast shipping, Secure packaging. A++ Seller :)
i***l (1778)- Feedback left by buyer.
Past year
Verified purchase
Very pleased with my purchase! Just as described. Shipping was fast and the box was well packed. HIGHLY RECOMMENDED SELLER! 5++++++++++ stars in every way!
g***a (2264)- Feedback left by buyer.
Past 6 months
Verified purchase
Wonderful magazines, like new, as described. Such a great price and were
mailed promptly. Just a great buy!
Product ratings and reviews
More to explore:
- Non-Fiction Diseases Hardcover Books,
- Non-Fiction Drugs Hardcover Books,
- Non-Fiction Diseases Paperback Fiction & Books,
- Non-Fiction Drugs Paperback Fiction & Books,
- Non-Fiction Diseases Fiction & Non-Fiction Books,
- Non-Fiction Fiction Books & Diseases Ex-Library,
- Non-Fiction Drugs Fiction & Non-Fiction Books,
- Marketing Adult Learning & University Books,
- Non-Fiction Drugs Fiction Books & 1950-1999 Publication Year,
- Non-Fiction Marketing Fiction & Non-Fiction Books